Matches in Wikidata for { <http://www.wikidata.org/entity/Q90046492> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q90046492 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90046492 description "bài báo khoa học" @default.
- Q90046492 description "scientific article published on 01 April 2019" @default.
- Q90046492 description "wetenschappelijk artikel" @default.
- Q90046492 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q90046492 name "Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer" @default.
- Q90046492 name "Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer" @default.
- Q90046492 type Item @default.
- Q90046492 label "Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer" @default.
- Q90046492 label "Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer" @default.
- Q90046492 prefLabel "Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer" @default.
- Q90046492 prefLabel "Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer" @default.
- Q90046492 P1433 Q90046492-B2AD3DC6-4DD1-4527-BA1A-ADF289540528 @default.
- Q90046492 P1476 Q90046492-364F6E10-A1DD-4DAC-AD8D-EC850671A368 @default.
- Q90046492 P2093 Q90046492-08D62518-9F98-4D68-8A62-B4970F01E01B @default.
- Q90046492 P2093 Q90046492-1C226B72-002E-45A2-823A-27B9CD165E60 @default.
- Q90046492 P2093 Q90046492-1DCF0089-F76F-472F-A6E3-C68683DD64D1 @default.
- Q90046492 P2093 Q90046492-7AB813CE-044A-478F-BBDC-9FECE3E87DAB @default.
- Q90046492 P2093 Q90046492-85226216-3B43-465F-AA1C-EF152083923E @default.
- Q90046492 P2093 Q90046492-F6951951-C839-4258-9C50-78F4415A20FF @default.
- Q90046492 P304 Q90046492-8769D997-777E-4EDA-B37B-4000508C438B @default.
- Q90046492 P31 Q90046492-AA8DC0AE-7C16-46D1-AC36-96923F6375F4 @default.
- Q90046492 P356 Q90046492-196A7215-7D91-4EF1-B88F-6F76EB52CD46 @default.
- Q90046492 P478 Q90046492-A17C4541-154A-419C-8DF1-943EEDA2C1ED @default.
- Q90046492 P577 Q90046492-5A48D99B-E115-40F4-97E1-6B2845AD15B1 @default.
- Q90046492 P921 Q90046492-476A528B-EDC6-42C0-90CB-FAEE79D47B4B @default.
- Q90046492 P356 MDZ063.027 @default.
- Q90046492 P1433 Q326122 @default.
- Q90046492 P1476 "Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer" @default.
- Q90046492 P2093 "J Zhu" @default.
- Q90046492 P2093 "J-A Huang" @default.
- Q90046492 P2093 "W Du" @default.
- Q90046492 P2093 "Y Zeng" @default.
- Q90046492 P2093 "Z Lian" @default.
- Q90046492 P2093 "Z Liu" @default.
- Q90046492 P304 "ii50" @default.
- Q90046492 P31 Q13442814 @default.
- Q90046492 P356 "10.1093/ANNONC/MDZ063.027" @default.
- Q90046492 P478 "30 Suppl 2" @default.
- Q90046492 P577 "2019-04-01T00:00:00Z" @default.
- Q90046492 P921 Q3658562 @default.